Seminal Music U.k Ltd

Seminal Music Uk Ltd from Holborn UK: a small, active company founded 11 years ago, employs just one person, and holds £127,614 in assets. It operates from a virtual address, managed by a solo founder who also serves as director and owner. The company regularly imports musical instruments and parts, with its last import operation dating back to March 2016.

The company’s website, Prescription PR, is a leading UK music PR company offering a range of services, including music promotion and marketing. They work with independent artists, entertainment industry clients, and record labels, boasting offices in London, Cambridge, and Manchester. The website details services like music website design, biography writing, and advice for musicians, with a strong emphasis on client testimonials and coverage. They even have a blog with articles on topics like SEO for musicians and building an online store.

Financially, Seminal Music Uk Ltd’s numbers are mixed. Cash bank on hand increased significantly by 140% to £41,000, which is a good sign. However, net assets decreased by 29% to £23,000. Bank borrowings increased by 2.5% to £9,300, and trade debtors decreased by 86%, which could be a concern. Creditors also decreased by 18%, suggesting improved debt management. As a small company, it meets two of three criteria for classification (turnover under £10.2 million, assets under £5.1 million, and fewer than 50 employees). The absence of an auditor mentioned likely means the financial statements are unaudited.

The company’s growth is evident in its increasing coverage and client list, but the fluctuating financials suggest it’s navigating a competitive market—and perhaps burning through cash a little faster than it's bringing it in.

Registered in England/Wales under the registration number 08905460, with a registered address at WC1A 2SL, England, Holborn, London, C/O Cc Young & Co, 3rd Floor, The Bloomsbury Building, 10 Bloomsbury Way.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.